PANC — Panacos Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$8.68m
- $0.18m
R2003 December 27th | R2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.08 | 1.34 | 1.05 | 0.284 | 0.18 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.41 | 13.3 | 61 | 42 | 39.2 |
Operating Profit | -4.33 | -12 | -60 | -41.7 | -39 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.51 | -12 | -59.1 | -38.1 | -37.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.51 | -12 | -59.1 | -38.1 | -37.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.51 | -12 | -59.1 | -38.1 | -37.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -5.24 | -14 | -59.1 | -38.1 | -37.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -13 | -14.5 | -0.752 | -0.754 | -0.681 |
Dividends per Share |